Angela M. Falzone

Scientific Director, Portfolio Management Group
Janssen Pharmaceuticals

“My Purdue Pharmacy education gave me the tools to solve scientific and technical problems, the insights to view challenges from many perspectives, and the tenacity to work to optimal solutions.”
  • BS 1984, Pharmacy, Philadelphia College of Pharmacy, University of the Sciences
  • PhD 1990, Industrial and Physical Pharmacy, Purdue University
Career Highlights
  • Filing, approval, and launch of Levaquin Tablet Product
  • Designing of equipment and process for combination product eliminating 12 manual steps and reducing solvent usage significantly
  • Successful restart of Fort Washington Production Facility
  • Solving significant dosage form release testing variability issue resulting in EU patent
  • Successfully designing and implementing processes and procedures supporting small scale oral solid product development for early human studies

Angela Falzone has enjoyed a lengthy career working in various subsidiaries of Johnson and Johnson. Her initial role was as a formulator for the Robert Wood Johnson Pharmaceutical Research Institute where she developed a variety of products from anti-infective agents to oral contraceptives. Some of her many professional experiences included developing products from early formulation through approval and launch, providing technical support for commercial products in production facilities, designing processes and procedures for small scale formulation development to support initial human dosing, manufacturing clinical supplies to support studies at all phases of development, renovating and modernizing pilot plant facilities, and supervising scientific teams in the U.S. and Europe.

After more than a decade in pharmaceuticals, Angela moved to Cordis Corporation where she led teams designing equipment and developing manufacturing processes for drug device combination products. Her team grew into an internal consulting resource for other John and Johnson subsidiaries developing combination products. After several years working in combination product development, she moved to McNeil Consumer Healthcare where she was responsible for designing and implementing new product validation processes and procedures. She became part of the team that successfully restarted the Fort Washington production facility with primary responsibility for equipment qualification and cleaning validation.

Angela currently serves as Scientific Director in the Portfolio Management Group of Janssen Pharmaceuticals. In this role she leads cross functional teams in executing the pharmaceutical product development for new active pharmaceutical ingredients. She resides in Pennsylvania with her husband, Robert, and their two daughters, Rachel and Sara.